Also, Wang et al., through transcriptome-wide analysis and modeling of prognostic alternative splicing signatures in invasive BC, followed by qRT-PCR in TNBC patients, found exon-specific EPHX2 expression associated with patient status under neoadjuvant chemotherapy [16]. The gene discussed is EPHX2; the disease is breast cancer.